Medical workforce gap in developing countries is set to worsen

Godlee, Fiona
October 2007
BMJ: British Medical Journal (International Edition);10/27/2007, Vol. 335 Issue 7625, p843
Academic Journal
The author reports that the number of healthcare workers in sub-Saharan Africa must triple annually for 10 years if every person with HIV disease or the AIDs virus is to receive antiretroviral treatment. These findings were presented in a study published in the journal "AIDS Patient Care and STDs." The study reports that there are over five million people worldwide who need antiretroviral therapy but who do not receive it and limited human resources is a primary constraint to achieving universal health coverage for these diseases.


Related Articles

  • Implementation and Effectiveness of Antiretroviral Therapy in Greenland. Lohse, Nicolai; Ladefoged, Karin; Obel, Niels // Emerging Infectious Diseases;Jan2008, Vol. 14 Issue 1, p56 

    Analyses from the Danish HIV Cohort Study showed that, despite comparable economic means and general education of healthcare personnel, antiretroviral treatment of HIV in Greenland began later and has been implemented at a slower pace with lower therapeutic effectiveness than in Denmark....

  • HIV Testing and Treatment Among Tuberculosis Patients -- Kenya, 2006-2009. Sitienei, J.; Kipruto, H.; Nganga, L.; Ackers, M.; Odhiambo, J.; Laserson, K.; Nakashima, A. K.; Modi, S. // MMWR: Morbidity & Mortality Weekly Report;11/26/2010, Vol. 59 Issue 46, p1514 

    The article discusses a report on HIV data from Kenya's tuberculosis (TB) surveillance system from 2006 to 2009. The Kenya Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) added HIV testing and treatment to its TB surveillance program at the recommendation of the World Health...

  • The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda. Baggaley, Rachel; Doherty, Meg; Ball, Andrew; Ford, Nathan; Hirnschall, Gottfried // Clinical Infectious Diseases;2015 Supplement, Vol. 60, pS159 

    There is a clear convergence toward an overarching strategic use of antiretroviral drugs to prevent human immunodeficiency virus (HIV) infection. Four interventions-immediate antiretroviral therapy (ART) for the infected partner in a serodiscordant couple, preexposure prophylaxis (PrEP),...

  • Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective. Kaplan, Jonathan E.; Dominguez, Kenneth; Jobarteh, Kebba; Spira, Thomas J. // Clinical Infectious Diseases;2015 Supplement, Vol. 60, pS196 

    The author comments on guidelines issued by the World Health Organization (WHO) regarding post-exposure prophylaxis against human immunodeficiency virus (HIV). Topics discussed include limited availability of evidence supporting use of post-exposure prophylaxis in prevention of HIV infection,...

  • First WHO guidance on antiretrovirals in HIV prophylaxis.  // PharmacoEconomics & Outcomes News;8/4/2012, Issue 659, p2 

    The article reports on the publication of the first guideline by the World Health Organization in August 2012 on the use of antiretrovirals in pre-exposure prophylaxis for the management of people who are at risk of HIV infection.

  • Low Rates of Mother-to-Child HIV Transmission in a Routine Programmatic Setting in Lilongwe, Malawi Kim, Maria H.; Ahmed, Saeed; Preidis, Geoffrey A.; Abrams, Elaine J.; Hosseinipour, Mina C.; Giordano, Thomas P.; Chiao, Elizabeth Y.; Paul, Mary E.; Bhalakia, Avni; Nanthuru, Debora; Kazembe, Peter N. // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Background: The Tingathe program utilizes community health workers to improve prevention of mother-to-child transmission (PMTCT) service delivery. We evaluated the impact of antiretroviral (ARV) regimen and maternal CD4+ count on HIV transmission within the Tingathe program in Lilongwe, Malawi....

  • RAPID INCREASES IN NEWER HIV EPIDEMICS IN ASIA AND EASTERN EUROPE.  // Indian Journal of Medical Sciences;Jan2004, Vol. 58 Issue 1, p34 

    Reports on the rapid increase of HIV epidemics in Asia and Eastern Europe. Result of almost complete absence of large-scale HIV prevention or antiretroviral treatment programs; Likelihood of infection among women compared to men; Result of injection drug use and unsafe sex practices.

  • WHO's use of generic antiretrovirals needs support.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p2 

    Presents information on a program implemented by the World Health Organization to increase access to antiretrovirals for HIV-infected individuals in developing countries. Efforts to prove the bioequivalence of generic and brand-name antiretrovirals; Criticism of various international agencies...

  • HIV Treatment As Prevention: How Scientific Discovery Occurred And Translated Rapidly Into Policy For The Global Response. Cohen, Myron S.; Holmes, Charles; Padian, Nancy; Wolf, Megan; Hirnschall, Gottfried; Lo, Ying-Ru; Goosby, Eric // Health Affairs;Jul2012, Vol. 31 Issue 7, p1439 

    In 2011 interim results of HIV Prevention Trials Network study 052, a National Institutes of Health study designed to test the effectiveness of antiretroviral treatment against the spread of HIV, were reported. These results showed that in a stable relationship in which one member of the couple...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics